Canada Life’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
SCM
BI
VCM
AC
PM
DTC
Canada Life's KURA Position: Q1 2026 in Review
Canada Life held its Kura Oncology (KURA) position steady in Q1 2026 at 6,268 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1756.
Canada Life first reported a position in KURA in Q4 2018 and has held it in 29 quarters since. The position peaked at $367K in Q2 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.
- Canada Life held 6,268 shares of Kura Oncology worth $51K as of Q1 2026.
- Canada Life left its Kura Oncology share count unchanged in Q1 2026.
- Kura Oncology made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1756 holding.
- Canada Life first reported a position in Kura Oncology in Q4 2018 and has held it in 29 quarters since.
- Canada Life's Kura Oncology position peaked at $367K in Q2 2024.
- 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.